Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma. (Q51039603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

title

Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

5

John M Maris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Ami V Desai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

Elizabeth Fox

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

L Mary Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

Allison Pecha Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

publication date

12 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1047-1055

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

Low complex ganglioside expression characterizes human neuroblastoma cell lines.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Cell-Surface Ganglioside GD2 in the Immunohistochemical Detection and Differential Diagnosis of Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Clinical pharmacokinetics of therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

Immunogenicity of therapeutic proteins: clinical implications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-014-2575-9

10.1007/S00280-014-2575-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25212536 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference